Related Experiment Video
Updated: Jul 9, 2025
13:27
High-Throughput DNA Plasmid Multiplexing and Transfection Using Acoustic Nanodispensing Technology
Published on: August 8, 2019
8.9K
Automating CAR-T Transfection with Micro and Nano-Technologies
Tianmu Hu1, Arun Rk Kumar2,3,4, Yikai Luo2,3
1Engineering Science Programme, National University of Singapore, Singapore, 117575, Singapore.
Small Methods
|December 6, 2023
Summary
Automating micro and nano-tool methods for chimeric antigen receptor T cell (CAR-T) transfection is crucial for reducing therapy costs. This approach promises to overcome limitations of current viral vector and electroporation techniques in CAR-T manufacturing.
Area of Science:
- Biotechnology
- Oncology
- Cellular Engineering
Background:
- Cancer treatment faces challenges with traditional therapies lacking specificity and curative potential.
- Chimeric antigen receptor T cell (CAR-T) therapy offers a promising alternative but is limited by high manufacturing costs.
- The CAR-T manufacturing process includes cell isolation, transfection, and expansion, with transfection being a bottleneck for automation.
Purpose of the Study:
- To review advancements in micro and nano-engineering tools for CAR-T cell transfection.
- To discuss the automation potential of these micro and nano-tool methods.
- To encourage the development of automated transfection protocols for CAR-T manufacturing.
Main Methods:
- Review of current micro and nano-engineering tools used for CAR-T transfection.
- Discussion on the challenges and opportunities for automating these advanced transfection techniques.
- Analysis of existing automated methods for other CAR-T manufacturing stages.
Main Results:
- Micro and nano-tool methods offer higher throughput and cargo flexibility for CAR-T transfection compared to viral vectors and bulk electroporation.
- Automation of micro and nano-tool transfection methods is currently underexplored.
- Existing automation technologies for cell isolation and expansion highlight the need for similar advancements in transfection.
Conclusions:
- Automating micro and nano-tool based CAR-T transfection is essential to address the high cost and accessibility issues of CAR-T therapy.
- Further research and development are needed to bridge the gap in automating the transfection stage of CAR-T manufacturing.
- Successful automation of micro and nano transfection techniques could significantly accelerate the widespread adoption of CAR-T therapies.
